Samoš, M.; Bolek, T.; Stančiaková, L.; Péč, M.J.; Brisudová, K.; Škorňová, I.; Staško, J.; Mokáň, M.; Kubisz, P.
Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation? J. Clin. Med. 2022, 11, 6369.
https://doi.org/10.3390/jcm11216369
AMA Style
Samoš M, Bolek T, Stančiaková L, Péč MJ, Brisudová K, Škorňová I, Staško J, Mokáň M, Kubisz P.
Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation? Journal of Clinical Medicine. 2022; 11(21):6369.
https://doi.org/10.3390/jcm11216369
Chicago/Turabian Style
Samoš, Matej, Tomáš Bolek, Lucia Stančiaková, Martin Jozef Péč, Kristína Brisudová, Ingrid Škorňová, Ján Staško, Marián Mokáň, and Peter Kubisz.
2022. "Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?" Journal of Clinical Medicine 11, no. 21: 6369.
https://doi.org/10.3390/jcm11216369
APA Style
Samoš, M., Bolek, T., Stančiaková, L., Péč, M. J., Brisudová, K., Škorňová, I., Staško, J., Mokáň, M., & Kubisz, P.
(2022). Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation? Journal of Clinical Medicine, 11(21), 6369.
https://doi.org/10.3390/jcm11216369